Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025
| Title: | Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025 |
|---|---|
| Authors: | Cordes, Henrik; Annaert, Pieter; Balazki, Pavel; Benamara, Salih; Hernandes Bonan, Rodolfo; Butler, Andrew; Chenel, Marylore; Cui, Yunhai; Dallmann, André; de Witte, Wilhelmus E. A.; Demeester, Cleo; Feick, Denise; Gattacceca, Florence; Geci, René; Gerebtzoff, Grégori; Gruber, Andrea; Guimarães, Mariana; Hamadeh, Abdullah; Hanke, Nina; Ibarra, Manuel; Ince, Ibrahim; Kanacher, Tobias; Kuepfer, Lars; Mil, Felix; Montaseri, Ghazal; Nauwelaerts, Nina; Proenca, Susana; Schaller, Stephan; Schlender, Jan Frederik; Schneider, Annika R. P.; Sjögren, Erik; Solodenko, Juri; Staab, Alexander; Vrenken, Paul; Troisi, Carla; Teutonico, Donato |
| Publisher Information: | Uppsala universitet, Institutionen för farmaceutisk biovetenskap; Sanofi R&D, Res Pharmacometr, Frankfurt, Germany.; Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Drug Delivery & Disposit, Leuven, Belgium.; ESQlabs GmbH, Saterland, Germany.; Sanofi R&D, Discovery Pharmacometr, Paris, France.;Aix Marseille Univ, Canc Res Ctr Marseille, COMPutat Pharmacol & Clin Oncol Dept,INSERM,UM105, UMR7258,CNRS ,Inria Sophia Antipolis Mediterranee, Marseille, France.; BioNotus CommV, Niel, Belgium.; Med & Healthcare Prod Regulatory Agcy, London, England.; Pharmetheus AB, Uppsala, Sweden.; Boehringer Ingelheim Pharm GmbH & Co KG, Biberach, Germany.; Bayer HealthCare SAS, Lille, France.; Inria Sophia Antipolis Mediterranee, Computat Pharmacol & Clin Oncol Dept, Biot, France.; ESQlabs GmbH, Saterland, Germany.;Univ Hosp RWTH Aachen, Inst Syst Med Focus Organ Interact, Aachen, Germany.; Novartis, Biomed Res, Basel, Switzerland.; Bayer AG, Modeling & Simulat, Res & Dev, Pharmaceut, Berlin, Germany.; Univ Waterloo, Sch Pharm, Kitchener, ON, Canada.; Boehringer Ingelheim Pharm GmbH & Co KG, Ingelheim, Germany.; Univ Republica, Fac Chem, Dept Pharmaceut Sci, Montevideo, Uruguay.; Univ Hosp RWTH Aachen, Inst Syst Med Focus Organ Interact, Aachen, Germany.; Bayer AG, Model Informed Drug Dev, Res & Dev, Pharmaceut, Leverkusen, Germany.; Pharmetheus AB, Uppsala, Sweden; Pharmetheus AB, Uppsala, Sweden.;Natl & Kapodistrian Univ Athens, Dept Pharm, Zografos, Greece.; Sanofi R&D, Discovery Pharmacometr, Paris, France. |
| Publication Year: | 2026 |
| Collection: | Uppsala University: Publications (DiVA) |
| Subject Terms: | Pharmacology and Toxicology; Farmakologi och toxikologi |
| Description: | Developed at Bayer Technology Services, PK-Sim and MoBi transitioned into the Open Systems Pharmacology (OSP) Suite, released as free open-source software in 2017. An active community with stakeholders from academia, industries, and regulators contributes to the continuous improvement of open-source model-informed drug development (MIDD). This perspective summarizes the latest advancements presented at the second OSP Community Conference (OSP-CC) hosted from 29 to 30th of September 2025 at Sanofi Paris, that gathered over 100 attendees from more than 40 institutions. |
| Document Type: | article in journal/newspaper |
| File Description: | application/pdf |
| Language: | English |
| Relation: | CPT : Pharmacometrics and Systems Pharmacology (PSP), 2026, 15:3; PMID 41721751; ISI:001697623200001 |
| DOI: | 10.1002/psp4.70217 |
| Availability: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-582133; https://doi.org/10.1002/psp4.70217 |
| Rights: | info:eu-repo/semantics/openAccess |
| Accession Number: | edsbas.39AC1134 |
| Database: | BASE |